Finch Therapeutics Group Inc. Gains 36.73%
Mon, Mar 11, 2024 at 07:16 PM
Finch Therapeutics Group Inc. (FNCH:NASDAQ) jumped higher at $3.42, a gain of 36.7%. On Mon, Mar 11, 2024, FNCH:NASDAQ hit a New 2-Week High of $3.42. From Mon, Feb 26, 2024, the stock recorded 50.00% Up Days and 54.55% Green Days
About Finch Therapeutics Group Inc. (FNCH:NASDAQ)
Finch Therapeutics Group Inc is a clinical-stage microbiome therapeutics company. It is leveraging Human-First Discovery platform to develop a novel class of orally administered biological drugs.
Top 10 Gainers:
- Power & Digital Infrastructure Acquisition II Corp. (XPDB:NASDAQ), 181.44%
- SeaChange International, Inc. (SEAC:NASDAQ), 174.29%
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 160.8%
- Sizzle Acquisition Corp. (SZZL:NASDAQ), 125.23%
- Solidion Technology Inc. (STI:NASDAQ), 124.36%
- Kidpik Corp. (PIK:NASDAQ), 80.37%
- TC BioPharm (Holdings) plc (TCBP:NASDAQ), 61.32%
- The L.S. Starrett Company (SCX:NYSE), 58.87%
- Energem Corp (ENCP:NASDAQ), 42.3%
- Finch Therapeutics Group Inc. (FNCH:NASDAQ), 36.73%